Carregant...

The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys

Previous studies in Parkinsonian rats and monkeys have shown that β2-selective nicotinic acetylcholine receptor (nAChR) agonists reduce l-Dopa–induced dyskinesias (LIDs), a serious complication of l-Dopa therapy for Parkinson’s disease. Since rodent studies also suggested an involvement of α7 nAChRs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Danhui, McGregor, Matthew, Decker, Michael W., Quik, Maryka
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Pharmacology and Experimental Therapeutics 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165030/
https://ncbi.nlm.nih.gov/pubmed/25034405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.216283
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!